Literature DB >> 60050

The role of the acute phase reaction in inflammation.

M E Billingham, A H Gordon.   

Abstract

Inflammation and injury to tissue results in a variety of local and systemic events, however although the local events of oedema formation and cellular infiltration have received considerably more attention the systemic response to inflammation is no less profound. The particular systemic event which forms the substance of this communication is the change in the circulating levels of plasma proteins which occurs after inflammatory injury, and the manner in which these changes in plasma concentration are controlled by changes in plasma concentration are controlled by changes in the rate of synthesis. A discussion of the role of the liver in controlling inflammatory events, in relation to the synthesis of an anti-inflammatory protein has been given; the present work is an extension of this and describes the changes in concentration and synthesis rate of albumin, fibrinogen and alpha1 acid glycoprotein during adjuvant arthritis in the rat. The changes which occur are regulated at the liver by alteration of the rate of synthesis of the individual protein. For example albumin at the height of adjuvant arthritis falls to a third of its normal plasma level whereas the level of alpha1 acid glycoprotein increases up to twenty-fold; these changes are reflected by similar changes in their synthesis rate by the liver. The effect of the fall in albumin concentration on the plasma binding of anti-inflammatory drugs (and their toxicity) in relation to these findings will be discussed along with the biological role of the acute phase plasma proteins and hence the influence of the liver in the response to injury.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60050     DOI: 10.1007/bf01972208

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  17 in total

Review 1.  Regulation of antigenic expression.

Authors:  C A Apffel; J H Peters
Journal:  J Theor Biol       Date:  1970-01       Impact factor: 2.691

2.  Changes in the rates of synthesis of certain plasma proteins following tissue damage due to talc injection. A study using the perfused rat liver.

Authors:  A H Gordon; A Koj
Journal:  Br J Exp Pathol       Date:  1968-10

3.  Regulation of net biosynthesis of serum albumin and acute phase plasma proteins. Induction of enhanced net synthesis of fibrinogen, alpha1-acid glycoprotein, alpha2 (acute phase)-globulin, and haptoglobin by amino acids and hormones during perfusion of the isolated normal rat liver.

Authors:  D W John; L L Miller
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Role of the liver in inflammation.

Authors:  M E Billingham; A H Gordon; B V Robinson
Journal:  Nat New Biol       Date:  1971-05-05

6.  A case of angioneurotic oedema with a high content of non-functioning, double peaked C1 esterase inhibitor.

Authors:  U Axelsson; A B Laurell
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

7.  Abnormal drug metabolism in rats after an inflammatory insult.

Authors:  M W Whitehouse
Journal:  Agents Actions       Date:  1973-12

8.  Pulmonary emphysema and alpha 1-antitrypsin deficiency.

Authors:  D C Hutchison; P J Cook; C E Barter; H Harris; P Hugh-Jones
Journal:  Br Med J       Date:  1971-03-27

9.  Albumin synthesis by the perfused rat liver. A comparison of methods with special reference to the effect of dietary protein deprivation.

Authors:  R Hoffenberg; A H Gordon; E G Black
Journal:  Biochem J       Date:  1971-04       Impact factor: 3.857

10.  CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANT.

Authors:  B B NEWBOULD
Journal:  Br J Pharmacol Chemother       Date:  1963-08
View more
  17 in total

1.  Serum IgG, IgM and slow alpha-globulin levels in carrageenan-treated rats.

Authors:  E F Fowler; A W Thomson
Journal:  Br J Exp Pathol       Date:  1979-08

2.  The acute phase response of C3, C5, ceruloplasmin, and C-reactive protein induced by turpentine pleurisy in the rabbit.

Authors:  P C Giclas; U Manthei; R C Strunk
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

3.  Suppression of rat adjuvant disease by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the disease.

Authors:  A R Mackenzie; C R Pick; P R Sibley; B P White
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

4.  New drugs for inflammation - a clinical viewpoint for their assessment.

Authors:  B McConkey
Journal:  Agents Actions       Date:  1976-09

5.  Functionally active alpha2-macroglobulin and kinen release in synovial fluids of rheumatoid arthritis.

Authors:  U Hamberg; E Vahtera; L Moilanen
Journal:  Agents Actions       Date:  1978-01

6.  The modulation of inflammation by the acute phase reaction in adjuvant arthritis in rats.

Authors:  R Hirschelmann; R Schade; H Bekemeier
Journal:  Agents Actions       Date:  1981-12

7.  Correlation between the rise in acute phase proteins and histological evidence of ulceration in the rat following indomethacin treatment [proceedings].

Authors:  M E Billingham; M J Tucker
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

8.  Effect of iron chelation on inflammatory joint disease.

Authors:  F J Andrews; C J Morris; G Kondratowicz; D R Blake
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

9.  6-sulphanilamidoindazole arthritis of rats: relation between acute-phase proteins, degree of arthritis and treatment with soybean trypsin inhibitor.

Authors:  R Hirschelmann; R Schade; H Bekemeier
Journal:  Agents Actions       Date:  1980-11

10.  A new screen for anti-inflammatory agents. Estimation of rat serum acute phase alpha2-macroglobulin levels using an electroimmunoassay.

Authors:  B A Baldo; S C Chow; C Euers
Journal:  Agents Actions       Date:  1981-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.